Now showing items 1-1 of 1

    • Enhanced Ca2+-sensing receptor function in pulmonary hypertension 

      Yamamura, A.; Yamamura, H.; Yuan, J.X. (Pharmaceutical Society of Japan, 2013)
      Pulmonary arterial hypertension (PAH) is a rare, progressive, and fetal disease. The five-year survival rate after diagnosis is ~50%. In Japan, PAH is listed in the Specified Rare and Intractable Diseases. Pulmonary vascular ...